下一个黄金十年,药明生物仍是最好的选择

药时代
Sep 15

在前不久的药明生物首届CRDMO+开放日上,公司首席执行官陈智胜博士回顾过往多年的打拼历程时感概,自己十年前在苏州参加行业会议,大家共同畅想十年后或许能有1-2个中国创新药上市。没想到当时还是太保守了,现在做得远比想像中要好得多。中国创新药临床试验数量与美国并驾齐驱,交易总额也在全球处于领先。这一观点与被拜耳收购的AskBio的联合创始人、原CEO希拉·米哈伊尔(Sheila Mikhail)在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10